前收市價 | 61.95 |
開市 | 61.95 |
買盤 | 64.15 |
賣出價 | 67.10 |
拍板 | 450.00 |
到期日 | 2026-12-18 |
今日波幅 | 61.95 - 61.95 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 31 |
Apple reports better-than-estimated earnings and expands its buyback program by $110 billion, Amgen ‘very encouraged’ by preliminary data from a trial of a weight-loss drug, and Expedia reduces its sales outlook for the year.
Controversial businessman Martin Shkreli, the former CEO of Turing Pharmaceuticals who raised the price of an essential drug from $13.50 to $750 per pill overnight, appears to have gained a new enemy. In a lengthy post on X, Shkreli shares that he "met this kid in prison" who "wanted to remake his life in crypto trading." In what Mr. Shkreli described as a "gesture of friendship", he gifted the friend 5 million tokens of a soon-to-be-released new project Martin Shkreli is working on. Don't Miss:
Coinbase Global (COIN) surpassed estimates on both earnings and revenues, benefiting from the wave of revival in digital coin trading largely due to the launch of a series of new bitcoin ETFs in January.